Cyclopentanemethylamine → HCID 21434444, compound

HRID 2398174Notes

Reaction equation

C([O:3][C:4](=O)[NH:5][S:6]([C:9]1[CH:24]=[CH:23][C:12]2[CH2:13][CH2:14][N:15]([C:18](=[O:22])[N:19]([CH3:21])[CH3:20])[CH2:16][CH2:17][C:11]=2[CH:10]=1)(=[O:8])=[O:7])C.[CH:26]1([CH2:31][NH2:32])[CH2:30][CH2:29][CH2:28][CH2:27]1>>[CH:26]1([CH2:31][NH:32][C:4]([NH:5][S:6]([C:9]2[CH:24]=[CH:23][C:12]3[CH2:13][CH2:14][N:15]([C:18](=[O:22])[N:19]([CH3:20])[CH3:21])[CH2:16][CH2:17][C:11]=3[CH:10]=2)(=[O:7])=[O:8])=[O:3])[CH2:30][CH2:29][CH2:28][CH2:27]1

Participants

Reactant 2

HCID 80153Cyclopentanemethylamine

HCID 53895465HCID 53895465, compound

Product 1

HCID 21434444HCID 21434444, compound

Procedure

By the reaction of [(3-dimethylcarbamoyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)sulfonyl]carbamic acid ethyl ester with cyclopentylmethylamine in a manner analogous to that described in Example 12, there is obtained 1-cyclopentylmethyl-3-[(3-dimethylcarbamoyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-sulfonyl]urea, m.p. 165°-166° C.

Sources & evidence

ORD record: ord-d249c3698f4c41d48fbf955e06f86e2f
Source dataset: uspto-grants-1977_05
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US04024128

Reaction notes

Loading…